Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Toronto

$163,175.00

Characterization and mitigation of experimental and natural viral bioaerosols

EF 2016-17

Résumé
We have gained extraordinarily detailed knowledge in the past decade about the molecular nature of respiratory viruses, yetwe know relatively little about how they spread. Resolution of this issue is essential for developing evidence-based strategiesto prevent transmission of these viruses. The emergence of novel respiratory viruses such as the H7N9 avian influenza virusand the Middle East Respiratory Syndrome coronavirus (MERS-CoV) highlights the importance of identifying means bywhich to control infectious bioaerosols in order to reduce risk to the Canadian public. A decade ago SARS-CoV causeddeath and significant disruption; panic and alarm stemmed from the lack of knowledge of the mode(s) of transmission of thisnovel virus. Unfortunately, this question remains unresolved today.We have identified important knowledge gaps and we propose to develop sampling tools and evaluate methods to mitigatethe dispersion of natural and experimental aerosols. We have partnered with two Canadian companies and the Public HealthAgency of Canada to ensure efficient knowledge transfer about respiratory virus transmission into the applications sector.We will utilize our established in vitro and in vivo (ferret) transmission models for influenza virus, as wellas state-of-the-art aerosol characterization systems to evaluate a new viral aerosol detection instrument developed withAirmax. We will also use these systems to evaluate a novel application of a traditional germicidal approach that utilizespulsed ultraviolet developed by Topnotch. These findings will have a significant impact on how we apply infection preventionand control measures for seasonal and emerging/re-emerging respiratory viruses, whilst informing public health policy for thecontrol of these agents.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
478452-2015
Name nom
Mubareka, Samira
Department département
Laboratory Medicine and Pathobiology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
163175
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Characterization and mitigation of experimental and natural viral bioaerosols
Keyword
NSERC
Application summary
We have gained extraordinarily detailed knowledge in the past decade about the molecular nature of respiratory viruses, yetwe know relatively little about how they spread. Resolution of this issue is essential for developing evidence-based strategiesto prevent transmission of these viruses. The emergence of novel respiratory viruses such as the H7N9 avian influenza virusand the Middle East Respiratory Syndrome coronavirus (MERS-CoV) highlights the importance of identifying means bywhich to control infectious bioaerosols in order to reduce risk to the Canadian public. A decade ago SARS-CoV causeddeath and significant disruption; panic and alarm stemmed from the lack of knowledge of the mode(s) of transmission of thisnovel virus. Unfortunately, this question remains unresolved today.We have identified important knowledge gaps and we propose to develop sampling tools and evaluate methods to mitigatethe dispersion of natural and experimental aerosols. We have partnered with two Canadian companies and the Public HealthAgency of Canada to ensure efficient knowledge transfer about respiratory virus transmission into the applications sector.We will utilize our established in vitro and in vivo (ferret) transmission models for influenza virus, as wellas state-of-the-art aerosol characterization systems to evaluate a new viral aerosol detection instrument developed withAirmax. We will also use these systems to evaluate a novel application of a traditional germicidal approach that utilizespulsed ultraviolet developed by Topnotch. These findings will have a significant impact on how we apply infection preventionand control measures for seasonal and emerging/re-emerging respiratory viruses, whilst informing public health policy for thecontrol of these agents.